|
|
Preparation technology and preliminary evaluation of Orally Disintegrating Tablets of Compound Salvia Miltiorrhiza by three dimensions printing |
LI Yue-zhong1 TANG Liang1 YANG Ya-dong2 ZHANG Wen-yuan2▲ |
1.Institute of Health Food, Zhejiang Academy of Medical Sciences, Zhejiang Province, Hangzhou 310013, China;
2.Institute of Bioengineering, Zhejiang Academy of Medical Sciences, Zhejiang Province, Hangzhou 310013, China |
|
|
Abstract Objective To prepare Orally Disintegrating Tablets (ODT) of Compound Salvia Miltiorrhiza by three dimensions (3D) printing technology and make a preliminary evaluation.Methods Salvia Miltiorrhiza, Panax Notoginseng,Borneol, lactose, povidone K30, mannitol, aspartame, and silicon dioxide were mixed and used as the printing powders,and alcohol aqueous solution containing 2% PVP K30 was used as the binder.ODT of Compound Salvia Miltiorrhiza was prepared by 3D printing technology.The ODT was set 5 mm in radius, 0.1 mm in coating layer height, and 30 layers in layer number.Then the disintegration time, hardness, weight, taste, appearance, and internal structure of the ODT were detected.Results The ODT radius of Compound Salvia Miltiorrhiza was about (5.1±0.1) mm in radius, the thickness was (3.2±0.2) mm.The average mass of the tablets was 167.6 mg (RSD=3.40%) and the hardness of the tablets was (1.72±0.20) kg.The prepared tablets disintegrated within 1 min, with high porosity, good appearance and taste, slightly sweet.The results of scanning electron microscopy indicated that the microstructure of the tablets was uniform.Conclusion The 3D printed ODT of Compound Salvia Miltiorrhiza has high porosity, simple process, short disintegration time, good taste and appearance.It shows that 3D printed ODT of Compound Salvia Miltiorrhiza is feasible to some extent.
|
|
|
|
|
[1] |
Tian P,Yang F,Xu Y,et al.Oral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing[J].Drug Dev Ind Pharm,2018,44(12):1918-1923.
|
[2] |
Alhnan MA,Okwuosa TC,Sadia M,et al.Emergence of 3D printed dosage forms:opportunities and challenges[J].Pharm Res,2016,33(8):1817-1832.
|
[3] |
国家药典委员会.中华人民共和国药典:2015年版一部[M].北京:中国医药科技出版社,2015:1214.
|
[4] |
Zhang Y,Wang Y,Meng H,et al.Mechanisms of Fufang Danshen tablets on treating heart failure via regulating AT1-mediated PLA2-COX2/5-LOX metabolic pathway[J].Chin J Chin Mat Med,2018,43(12):2593-2599.
|
[5] |
Ren-an Q,Juan L,Chuyuan L,et al.Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats[J].J Ethnopharmacol,2014,156(2):190-198.
|
[6] |
王运赣,王宣.3D 打印技术(修订版)[M].武汉.华中科技大学出版社,2014:50.
|
[7] |
王运赣,王宣.黏结剂喷射与熔丝制造3D 打印技术[M].西安.西安电子科技大学出版社,2016:78.
|
[8] |
Zhang J,Vo AQ,Feng X,et al.Pharmaceutical Additive Manufacturing:a Novel Tool for Complex and Personalized Drug Delivery Systems[J].AAPS Pharm Sci Tech,2018,19(8):3388-3402.
|
[9] |
林启凤,杨帆,范凯燕,等.3D 打印速效救心口崩片的制备研究[J].广东药学院学报,2016,32(1):1-4.
|
[10] |
Khaled SA,Burley JC,Alexander MR,et al.3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles[J].J Control Release,2015,217(3):308-314.
|
[11] |
Yu DG,Branford-White C,Ma ZH,et al.Novel drug delivery devices for providing linear release profiles fabricated by 3DP[J].Int J Pharm,2009,370(1-2):160-166.
|
[12] |
Goyanes A,Buanz AB,Hatton GB,et al.3D printing of modified-release aminosalicylate (4-ASA and 5-ASA)tablets[J].Eur J Pharm Biopharm,2015,89(2):157-162.
|
[13] |
Awad A,Trenfield SJ,Gaisford S,et al.3D printed medicines:A new branch of digital healthcare[J].Int J Pharm,2018,548(1):586-596.
|
[14] |
Osouli-Bostanabad K,Adibkia K.Made-on-demand,complex and personalized 3D-printed drug products[J].Bioimpacts,2018,8(2):77-79.
|
[15] |
Prasad LK,Smyth H.3D printing technologies for drug delivery:a review[J].Drug Dev Ind Pharm,2016,42(7):1019-1031.
|
[16] |
Goyanes A,Robles MP,Buanz A,et al.Effect of geometry on drug release from 3D printed tablets[J].Int J Pharm,2015,494(2):657-663.
|
[17] |
Trenfield SJ,Awad A,Goyanes A,et al.3D Printing pharmaceuticals:drug development to frontline care[J].Trends Pharmacol Sci,2018,39(5):440-451.
|
[18] |
Yu DG,Branford-White C,Yang YC,et al.A novel fast disintegrating tablet fabricated by three-dimensional printing[J].Drug Develop Ind Pharm,2009,35(12):1530-1536.
|
[19] |
Singhvi G,Patil S,Girdhar V,et al.3D-printing:an emerging and a revolutionary technology in pharmaceuticals[J].Panminerva Med,2018,60(4):170-173.
|
[20] |
Pravin S,Sudhir A.Integration of 3D printing with dosage forms:A new perspective for modern healthcare[J].Biomed Pharmacother,2018,107(2):146-154.
|
|
|
|